IBRUTINIB | N210563 | PHARMACYCLICS LLC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2015-01076 | 8754090 | IPR | Coalition for Affordable Drugs IV LLC | Institution Denied | 2015-04-20 | — |
| IPR2019-00865 | 9795604 | IPR | Sandoz Inc. et al. | Final Written Decision | 2019-03-21 | — |
| PGR2024-00009 | 11672803 | PGR | BeiGene USA, Inc. et al. | Final Written Decision | 2023-11-01 | 2025-05-01 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Pharmacyclics LLC v. BeOne Medicines USA, Inc. et al 6 patentsibrutinib (IMBRUVICA®); zanubrutinib (BRUKINSA®) | D. Del. | 2023-06-13 | Terminated 2025-09-30 | — |
| D. Del. | 2020-04-24 | Terminated 2021-03-31 | — | |
| D. Del. | 2019-03-01 | Terminated 2021-08-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7514444 | Dec 28, 2026PED: Jun 28, 2027 | PED | Yes | Yes | — | — |
| 8008309 | Nov 13, 2027PED: May 13, 2028 | PED | Yes | Yes | — | — |
| 8476284 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | — | — | |
| 8497277 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | — | — | |
| 8563563 | Apr 26, 2027PED: Oct 26, 2027 | PED | — | — | — | |
| 8697711 | Dec 28, 2026PED: Jun 28, 2027 | PED | Yes | Yes | — | — |
| 8703780 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | — | — | |
| 8735403 | Dec 28, 2026PED: Jun 28, 2027 | PED | Yes | Yes | — | — |
| 8754091 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | Yes | — | — |
| 8952015 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | — | — | |
| 8957079 | Dec 28, 2026PED: Jun 28, 2027 | PED | Yes | Yes | — | — |
| 8999999 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 9125889 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 9181257 | Dec 28, 2026PED: Jun 28, 2027 | PED | Yes | — | — | — |
| 9296753 | Oct 30, 2033PED: Apr 30, 2034 | PED | Yes | — | — | — |
| 9655857 | Mar 3, 2036PED: Sep 3, 2036 | PED | — | Yes | — | — |
| 9725455 | Jun 3, 2033PED: Dec 3, 2033 | PED | Yes | — | — | — |
| 9795604 | Oct 24, 2034PED: Apr 24, 2035 | PED | — | — | — | |
| 9801881 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 9801883 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 10004746 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 10010507 | Mar 3, 2036PED: Sep 3, 2036 | PED | — | Yes | — | — |
| 10016435 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 10106548 | Jun 3, 2033PED: Dec 3, 2033 | PED | Yes | Yes | — | — |
| 10125140 | Jun 3, 2033PED: Dec 3, 2033 | PED | Yes | Yes | — | — |
| 10213386 | Mar 3, 2036PED: Sep 3, 2036 | PED | — | Yes | — | — |
| 10463668 | Oct 24, 2034PED: Apr 24, 2035 | PED | — | — | — | |
| 10478439 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 10695350 | Oct 24, 2034PED: Apr 24, 2035 | PED | — | — | — | |
| 10751342 | Jun 3, 2031PED: Dec 3, 2031 | PED | — | — | — | |
| 10752634 | Jun 3, 2033PED: Dec 3, 2033 | PED | — | Yes | — | — |
| 10828259 | Mar 3, 2036PED: Sep 3, 2036 | PED | — | Yes | — | — |
| 10961251 | Jun 3, 2033PED: Dec 3, 2033 | PED | — | Yes | — | — |
| 11672803 | Jun 3, 2031 | — | — | — | — | |
| 12551448 | Mar 3, 2036 | — | — | Yes | — | — |
| Code | Date | Status |
|---|---|---|
| NPP | Aug 24, 2025 | Expired |
| ODE-405 | Aug 24, 2029 | Active |
| PED | Feb 24, 2030 | Active |